Oticon Medical
Clinical trials sponsored by Oticon Medical, explained in plain language.
Now part of
Demant A/S
DEMANT
COPENHAGEN
Hearing implant manufacturer, part of the Demant group.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hearing implant trial aims to help kids hear better Results expected Oct 2026 (estimated)
- Which bone conduction hearing device works best? new study aims to find out. Results expected Oct 2026 (estimated)
- Hearing implants without the OR: a safer, simpler approach? Results expected Mar 2027 (estimated)
- New hearing device for teens: can it restore sound? Results expected Apr 2027 (estimated)